| Particulars |
|
|
|
| Company Name
| Sanofi India Ltd
| Year End
| 202312
|
| Full Year |
| Equity (₹ Cr.) |
23.03 |
B.V. (₹) |
297.30 |
| Sales(₹ Cr.) |
2,851.10 |
NP (₹ Cr.) |
590.52 |
| NP Var% |
12.00 |
Div% |
1,670.00 |
| CPS(₹) |
273.60 |
EPS (₹) |
256.40 |
| Traded Value(₹ Lakhs) |
47.33 |
52 Week High |
10,526.00 |
| 52 Week Low |
5,173.00 |
Price BSE |
5,450.00 |
| Price NSE |
5,457.00 |
Market Capital (₹ Cr.) |
12,552.27 |
| P/C Ratio |
19.90 |
P/E Ratio |
21.30 |
| Price Vs.BV |
18.33 |
|
| Latest Quarter |
| Year End |
202409 |
Sales (₹ Cr.) |
524.00 |
| NP(₹ Cr.) |
82.20 |
NP Var % |
2.00 |
| Trailing Twelve Months |
| Year End |
202409 |
Sales |
2,192.20 |
| OPM |
20.99 |
NP |
421.55 |
| NP Var% |
-8.51 |
EPS |
183.05 |
| PE |
29.78 |
|
|